Literature DB >> 7487870

Kukoamine A and other hydrophobic acylpolyamines: potent and selective inhibitors of Crithidia fasciculata trypanothione reductase.

J A Ponasik1, C Strickland, C Faerman, S Savvides, P A Karplus, B Ganem.   

Abstract

The enzyme trypanothione reductase (TR), together with its substrate, the glutathione-spermidine conjugate trypanothione, plays an essential role in protecting parasitic trypanosomatids against oxidative stress and is a target for drug design. Here we show that a naturally occurring spermine derivative, the antihypertensive agent kukoamine A [N1N12-bis(dihydrocaffeoyl)-spermine] inhibits TR as a mixed inhibitor (Ki = 1.8 microM, Kii = 13 microM). Kukoamine shows no significant inhibition of human glutathione reductase (Ki > 10 mM) and thus provides a novel selective drug lead. The corresponding N1N8-bis(dihydrocaffeoyl)spermidine derivative was synthesized and acted as a purely competitive inhibitor with Ki = 7.5 microM. A series of mono- and di-acylated spermines and spermidines were synthesized to gain an insight into the effect of polyamine chain length, the nature and position of the acyl substituent and the importance of conformational mobility. These compounds inhibited TR with Ki values ranging from 11 to 607 microM.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7487870      PMCID: PMC1136010          DOI: 10.1042/bj3110371

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures.

Authors:  T J Benson; J H McKie; J Garforth; A Borges; A H Fairlamb; K T Douglas
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

2.  X-ray structure of trypanothione reductase from Crithidia fasciculata at 2.4-A resolution.

Authors:  J Kuriyan; X P Kong; T S Krishna; R M Sweet; N J Murgolo; H Field; A Cerami; G B Henderson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

3.  Refined structure of glutathione reductase at 1.54 A resolution.

Authors:  P A Karplus; G E Schulz
Journal:  J Mol Biol       Date:  1987-06-05       Impact factor: 5.469

4.  Identification of a novel, thiol-containing co-factor essential for glutathione reductase enzyme activity in trypanosomatids.

Authors:  A H Fairlamb; A Cerami
Journal:  Mol Biochem Parasitol       Date:  1985-02       Impact factor: 1.759

5.  Statistical analysis of enzyme kinetic data.

Authors:  W W Cleland
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

6.  Substrate binding and catalysis by glutathione reductase as derived from refined enzyme: substrate crystal structures at 2 A resolution.

Authors:  P A Karplus; G E Schulz
Journal:  J Mol Biol       Date:  1989-11-05       Impact factor: 5.469

7.  Trypanothione is the primary target for arsenical drugs against African trypanosomes.

Authors:  A H Fairlamb; G B Henderson; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

8.  "Subversive" substrates for the enzyme trypanothione disulfide reductase: alternative approach to chemotherapy of Chagas disease.

Authors:  G B Henderson; P Ulrich; A H Fairlamb; I Rosenberg; M Pereira; M Sela; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

Review 9.  Metabolism and functions of trypanothione in the Kinetoplastida.

Authors:  A H Fairlamb; A Cerami
Journal:  Annu Rev Microbiol       Date:  1992       Impact factor: 15.500

10.  Structure of trypanothione reductase from Crithidia fasciculata at 2.6 A resolution; enzyme-NADP interactions at 2.8 A resolution.

Authors:  S Bailey; A H Fairlamb; W N Hunter
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-03-01
View more
  8 in total

Review 1.  Parasite-specific trypanothione reductase as a drug target molecule.

Authors:  R Luise Krauth-Siegel; Oliver Inhoff
Journal:  Parasitol Res       Date:  2003-04-23       Impact factor: 2.289

Review 2.  Cation-pi bonding and amino-aromatic interactions in the biomolecular recognition of substituted ammonium ligands.

Authors:  N S Scrutton; A R Raine
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

3.  Antiplasmodial and antitrypanosomal activity of plants from the Kingdom of Saudi Arabia.

Authors:  Essam Abdel-Sattar; Fathalla M Harraz; Soliman M A Al-Ansari; Sahar El-Mekkawy; Chikara Ichino; Hiroaki Kiyohara; Kazuhiko Otoguro; Satoshi Omura; Haruki Yamada
Journal:  J Nat Med       Date:  2008-12-10       Impact factor: 2.343

4.  Antidepressant-like effects of lycii radicis cortex and betaine in the forced swimming test in rats.

Authors:  Soo Jeong Kim; Lee Lee; Ji Hyun Kim; Tae Hee Lee; Insop Shim
Journal:  Biomol Ther (Seoul)       Date:  2013-01       Impact factor: 4.634

5.  Trypanothione reductase: a viable chemotherapeutic target for antitrypanosomal and antileishmanial drug design.

Authors:  M Omar F Khan
Journal:  Drug Target Insights       Date:  2007-06-19

Review 6.  Mini review on tricyclic compounds as an inhibitor of trypanothione reductase.

Authors:  Suresh Kumar; Md Rahmat Ali; Sandhya Bawa
Journal:  J Pharm Bioallied Sci       Date:  2014-10

7.  Investigation of trypanothione reductase as a drug target in Trypanosoma brucei.

Authors:  Daniel Spinks; Emma J Shanks; Laura A T Cleghorn; Stuart McElroy; Deuan Jones; Daniel James; Alan H Fairlamb; Julie A Frearson; Paul G Wyatt; Ian H Gilbert
Journal:  ChemMedChem       Date:  2009-12       Impact factor: 3.466

8.  Development of a novel virtual screening cascade protocol to identify potential trypanothione reductase inhibitors.

Authors:  Rolando Perez-Pineiro; Asdrubal Burgos; Deuan C Jones; Lena C Andrew; Hortensia Rodriguez; Margarita Suarez; Alan H Fairlamb; David S Wishart
Journal:  J Med Chem       Date:  2009-03-26       Impact factor: 7.446

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.